STOCK TITAN

BETTER THERAPEUTICS INC - $BTTX STOCK NEWS

Welcome to our dedicated page for BETTER THERAPEUTICS news (Ticker: $BTTX), a resource for investors and traders seeking the latest updates and insights on BETTER THERAPEUTICS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BETTER THERAPEUTICS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BETTER THERAPEUTICS's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.51%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.43%
Tags
conferences clinical trial
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.08%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.17%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.88%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.66%
Tags
none
BETTER THERAPEUTICS INC

Nasdaq:BTTX

BTTX Rankings

BTTX Stock Data

648.74k
21.11M
53.34%
2.95%
3.9%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States of America
San Francisco

About BTTX

better therapeutics (f/k/a farewell) is developing prescription digital therapeutics for treating chronic disease. its innovative solution combines software, human coaching augmented by artificial intelligence, and advanced analytics to address the behaviors at the root cause of most chronic conditions, in a manner that can scale rapidly to address millions of covered lives. better’s digital therapeutics are based on well-established evidence, fit within existing clinical treatment guidelines, and can be used with or without other interventions. better believes non-drug treatment options are essential to reducing the unnecessary health and cost burden of chronic disease on individuals, payers, and the nation.